<DOC>
	<DOCNO>NCT02596945</DOCNO>
	<brief_summary>This non-interventional , observational study investigates efficacy , safety usability methoxy polyethylene glycol epoetin beta participant peritoneal dialysis . Participants prescribe methoxy polyethylene glycol epoetin beta doctor meet selection criterion enrol documented study period 9 month treatment methoxy polyethylene glycol epoetin beta respect efficacy , safety usability .</brief_summary>
	<brief_title>Observational Study Methoxy Polyethylene Glycol Epoetin Beta Daily Use Participants Peritoneal Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Participants peritoneal dialysis Need Erythropoiesis Stimulating Agent ( ESA ) therapy Prescription methoxy polyethylene glycol epoetin beta doctor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>